Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial assessing Bexagliflozin as monotherapy in adults with Type 2 Diabetes Mellitus has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects [Phase 1]
Phase 1 study assessing the effect of a high-fat meal on the pharmacokinetics of bexagliflozin in healthy subjects, completed with posted re…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment [Phase 3]
Phase 3 trial update on safety and efficacy of Bexagliflozin in type 2 diabetes patients with moderate renal impairment has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects [Phase 1]
Phase 1 study evaluating the effects of probenecid, rifampin, and verapamil on bexagliflozin in healthy subjects completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating the effects of an SGLT2 inhibitor on glucose flux, lipolysis, and exercise in adults with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus [Phase 2, Phase 3]
Phase 2/3 trial investigating antimicrobial photodynamic therapy for chronic periodontitis in patients with type 2 diabetes mellitus or pred…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) [Phase 2]
Phase 2 trial update for Autologous Neo-Kidney Augment (NKA) in patients with Type 2 Diabetes and Chronic Kidney Disease; study terminated w…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 dose range finding study assessing Bexagliflozin tablets in adults with Type 2 diabetes mellitus; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics [Phase 4]
A Phase 4 trial assessing the effects of empagliflozin on left ventricular diastolic function in adults with type 2 diabetes and diastolic d…
-
FDA approval · 2021-04-16FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original application for Metformin Hydrochloride Extended-Release Tablets, a generic metformin product…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes [Phase 2]
Phase 2 trial comparing a new drug to placebo and an existing Type 2 diabetes treatment has completed; results posted in 2021.
-
FDA approval · 2021-04-12FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for OZEMPIC (semaglutide) from Novo Nordisk, which updates the drug's label and may add a new in…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling [Phase 4]
A Phase 4 trial exploring the relationship between insulin resistance and statin-induced type 2 diabetes with integrative omics profiling.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes. [Phase 4]
Phase 4 trial update for TriMaster evaluating a combination of a DPP-4 inhibitor, SGLT2 inhibitor, and thiazolidinedione as third-line thera…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update on pulsatile insulin infusion therapy in patients with Type 1 and Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial assessing the impact of intensive short-term drug therapy in patients with type 2 diabetes mellitus.
-
FDA approval · 2021-03-31FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved a supplemental application for Colesevelam hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Digital Self-Management and Health Coaching for Type 2 Diabetes - Impact on Diabetes Clinical and Wellness Indicators [NA]
A completed clinical trial evaluating digital self-management and health coaching for adults with Type 2 diabetes, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management [Phase 4]
A Phase 4 clinical trial compares lobeglitazone with pioglitazone as initial triple therapy for type 2 diabetes, with status currently unkno…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes
A completed clinical trial update analyzing characteristics of people taking empagliflozin for type 2 diabetes based on German registry data…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial update for ORMD-0801 in Type 2 diabetes mellitus; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD [Phase 4]
A Phase 4 trial update comparing dabigatran to warfarin in atrial fibrillation patients with type 2 diabetes and chronic kidney disease. The…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial comparing MAGE of Anagliptin with Sitagliptin in type 2 diabetes has completed.
-
FDA approval · 2021-03-23FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Effect of Pioglitazone on T2DM Patients With COVID-19 [Phase 4]
Clinical trial evaluating the effect of pioglitazone in patients with type 2 diabetes and COVID-19 is in Phase 4; current status is unknown.